EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY-NC-ND 4.0

Protocol to identify small-molecule inhibitors against cancer drug resistance

Juan Wei, She-Yu Zhang, Xue-Yuan Zhou, Yong Wei, Hao-Ran Jia, Qin Wu, Weihong Tan

STAR Protocols · 2025

DOI: 10.1016/j.xpro.2025.103605 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift STAR Protocols, 2025. Verfasst von Juan Wei und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Science, Tianjin University, Tianjin, China. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Small Molecule Libraries, Antineoplastic Agents, High-Throughput Screening Assays. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug resistance has emerged as a critical challenge in clinical cancer treatment. Here, we present a high-throughput screening protocol to identify therapeutic small-molecule inhibitors against drug-resistant cancer cells. We detail the steps for constructing drug-resistant cell models, executing the chemical screening process, and performing data analysis and validation. This protocol facilitates the rapid identification of therapeutic strategies for different types of drug-resistant cancers and aids in studying mechanisms. For complete details on the use and execution of this protocol, please refer to Zhang et al.1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmSmall Molecule LibrariesAntineoplastic AgentsHigh-Throughput Screening AssaysNeoplasmsHumansCell Line, TumorDrug Screening Assays, Antitumor

Stichwörter der Autor:innen

cancercell-based assayshigh-throughput screening

Substanzen

Small Molecule LibrariesAntineoplastic Agents

Autor:innen und Institutionen

  • School of Science, Tianjin University, Tianjin, China.
  • School of Life Sciences, Tianjin University, Tianjin, China.
  • Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
  • Institute of Molecular Medicine (IMM), Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: jiahr@ucas.ac.cn.
  • Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China. Electronic address: wuqin@ibmc.ac.cn.
  • Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China; Institute of Molecular Medicine (IMM), Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Ele…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wei, J., Zhang, S. Y., Zhou, X. Y., Wei, Y., Jia, H. R., Wu, Q., & Tan, W. (2025). Protocol to identify small-molecule inhibitors against cancer drug resistance. STAR Protocols. https://doi.org/10.1016/j.xpro.2025.103605

Vancouver

Wei J, Zhang SY, Zhou XY, Wei Y, Jia HR, Wu Q, et al. Protocol to identify small-molecule inhibitors against cancer drug resistance. STAR Protocols. 2025. doi:10.1016/j.xpro.2025.103605

BibTeX
@article{Wei2025,
  author = {Wei, Juan and Zhang, She-Yu and Zhou, Xue-Yuan and Wei, Yong and Jia, Hao-Ran and Wu, Qin and Tan, Weihong},
  title = {Protocol to identify small-molecule inhibitors against cancer drug resistance},
  journal = {STAR Protocols},
  year = {2025},
  doi = {10.1016/j.xpro.2025.103605}
}
Kostenlos starten →